Palau
Reimbursed Care Access
Palau regulates controlled drugs through schedules in its national code (Title 34/Chapter 31 referenced by the Penal Code). Most classical psychedelics (psilocybin/psilocin, MDMA, mescaline, DMT and related tryptamines, 2C-series, ibogaine, etc.) are scheduled/controlled with no authorised routine medical/insured use outside approved research. Ketamine is an internationally recognised medical anaesthetic and is the only compound among those listed that is routinely used in clinical medicine globally; Palau’s laws treat controlled substances via schedules that allow medical/clinical use under regulation but do not indicate a national reimbursement program or specific approval of esketamine (Spravato) for psychiatric indications in Palau.
No clinical trials found for this country yet.